Biofourmis Care:
First of its kind technology-enabled care delivery solution
Powered by our innovative platform, Biofourmis offers connected, configurable, and personalized care options to manage patients both virtually and in-person. For healthcare providers and risk-bearing entities, we can improve clinical, operational, and economic outcomes across the care continuum.
Solutions
Hospital at home
Using dynamic care pathways, continuous monitoring, care coordination tools, and configurable services, we enable clinicians to deliver inpatient-level care at home.
Biofourmis Care can help our healthcare partners to:
Improve clinical outcomes with lower rates of mortality1
Increase bed-days saved and create capacity for more acute patients
Increase patient satisfaction by treating patients where they are most comfortable2
Deliver remote care similar to in patient workflows through EMR integration
Utilize a coordinated network of in-home partners providing services such as: nursing, phlebotomy, infusion, wound care, and other ancillary services*
Maximize patient-to-staff ratio with scalable technology-enabled platform3
Transitional care
Our transitional care solutions allow patients to move seamlessly from acute to ambulatory to chronic care management, virtually and at home.
We provide:
AI-guided software and clinically-actionable notifications helps dedicated, licensed, clinical care teams detect and intervene sooner
Episodic or continuous monitoring leveraging a device-agnostic portfolio of FDA-cleared devices
Superior patient engagement using patient app, including task reminders, symptom tracking questionnaires, educational content, and adherence tracking
Time-sensitive patient outreach via text, talk, and video conferencing capability
Utilize a coordinated network of in-home partners providing services such as: nursing, phlebotomy, infusion, wound care, and other ancillary services*
Disease-specific pathways including cardiometabolic, pulmonary, oncologic, infectious disease, and post-procedure transitional conditions
Digital disease management
We offer virtual, value-based care for patients with chronic conditions, and streamlined patient management for clinicians.
We enhance our partners’ organizational capacity, staff efficiency, profitability, and quality of care with3:
A broad range of monitoring through clinically validated devices that enable continuous data capture
Advanced analytics that improve medication optimization for more personalized clinical care
Remote care for patients with cardiometabolic, oncologic, and pulmonary conditions
Omnipresent support for patients from our national provider network of MDs, RNs, NPs, and Health Navigators, who engage patients to help ensure compliance and clinical goals
Scalable care management capabilities that improves patient satisfaction and patient satisfaction and patient engagement
Population health-based, disease specific care pathways for patient identification help improve care coordination and quality measures
Interested in learning more?
Savings and efficiency
Just as we carefully gather and track biomarker data on every patient, we also study the results our partners gain from using our technology.
reduction in readmissions for patients receiving acute care at home4
average cost reduction for acute care patients receiving hospital-level care at home4
patient bed days in the hospital saved5
Engagement and empowerment
Biofourmis Care patients report a 98+% level of satisfaction3. Patient satisfaction is strongly connected to comfort, and we believe that people are more comfortable healing in their own home. But our model of care delivery can positively impact patient experiences in even more ways:
Access
Improved access to specialists for rural and underserved populations
Safety
Reduced risk of hospital-acquired complications by healing at home
Support
24/7 clinical and technical support for patients
Savings
Reduced costs and travel time to care facilities for patients and families
Engagement
Increased engagement via individualized care plans, daily progress tracking, and ongoing personalized education
1. Leong MQ, Lim CW, Lai YF. Comparison of Hospital-at-Home models: A systematic review of reviews. BMJ Open 2021;11:e043285. doi: 10.1136/bmjopen-2020-043285.
2. Maniaci MJ, Torres-Guzman RA, Garcia JP, Avila FR, Maita KC, Forte AJ, Paulson MR. Overall patient experience with a virtual hybrid hospital at home program. SAGE Open Med. 2022 Apr 22;10:20503121221092589. doi: 10.1177/20503121221092589. PMID: 35481244; PMCID: PMC9036381.
3. Biofourmis data on file.
4. Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL.Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17. PMID: 31842232.
5. As of 12/12/22 all time patients on Biofourmis platform.
*Subject to geography and connectivity